Hyaluronidase Recombinant Human Patent Expiration

Hyaluronidase Recombinant Human was first introduced by Halozyme Therapeutics Inc in its drug Hylenex Recombinant on Dec 2, 2005.


Hyaluronidase Recombinant Human Patents

Given below is the list of patents protecting Hyaluronidase Recombinant Human, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Hylenex Recombinant US7767429 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof Sep 23, 2027 Halozyme Therap


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳